The healthcare and pharmaceutical sector today showed a two-tiered performance: Pfizer fell 0.8%, Johnson & Johnson fell 0.9%, major pharma companies weakened with the sector in the absence of news; CRISPR Therapeutics rose 4.5%, as news of a breakthrough in gene-editing technology continues to be priced in; Brain Regen Tech rose 6.2%, a random strengthening of Hong Kong small-cap stocks amid a news vacuum today; Intuitive Surgical fell 2.3%, as medical devices also lacked specific catalysts today; Recursion fell 0.9%, with the AI drug discovery narrative quiet for now.
Major pharma steadily declined, Biotech and gene-editing moved on their own paths, and Intuitive Surgical pulled back along with the major pharma companies.
But I'm wondering if CRSP's current gene-editing rally is due to real new progress, or just a technical rebound 🤔
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
